Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.
Juniper Behavioral Health
Series B in 2025
Juniper develops a behavioral health practice management software designed to streamline the logistical operations of clinics. The platform integrates various functions, including patient onboarding and billing, into a single cohesive system. It focuses on reducing manual tasks that clinicians typically encounter, thereby enhancing efficiency. Additionally, Juniper's software emphasizes compatibility with third-party applications, allowing for better automation and accountability across clinic operations. This holistic approach enables clinics to improve their reporting capabilities and manage their databases more effectively, ultimately supporting their growth and operational scalability.
Slingshot AI
Series A in 2025
Slingshot AI is an AI research company focused on enhancing global access to mental healthcare. Based in NYC and London, Slingshot AI develops technology aimed at improving human well-being, fostering connections, and aiding adaptation to future changes. The company leverages advanced large language models to understand the complexities of human psychology, providing tools that empower individuals to manage daily challenges and receive effective mental support. Their cross-disciplinary team includes researchers, engineers, and mental health experts dedicated to this mission.
Hippocratic AI
Series B in 2025
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.
Infinitus Systems
Series C in 2024
Infinitus Systems is an AI healthcare company focused on automating phone communications within the healthcare sector. By streamlining tedious and time-consuming phone-based processes, the company aims to enhance access to therapy, improve patient adherence, and lower costs for patients. Its communication tool allows users to submit call requests effortlessly, track updates, and receive notifications upon task completion, thereby simplifying administrative burdens. Infinitus Systems addresses the complexity and expenses associated with back-office administration in healthcare, contributing to the overall efficiency of the system. With significant backing from prominent investors, the company is positioned to make a meaningful impact in the healthcare landscape.
Tennr is a healthcare AI startup focused on optimizing healthcare operations by automating back-office tasks. The company's platform leverages AI technology to replace traditional faxing systems and streamline communication processes in healthcare, ensuring patients receive timely care. By automating workflows, verifying information, analyzing data entry, and handling decision-making nuances, Tennr enables healthcare practices of all sizes to enhance their operational efficiency with high-quality automation.
Alchemy
Seed Round in 2024
Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy to expand access for patients, improve health outcomes, and increase the financial impact of a clinic's pharmacy program.
Scribenote
Seed Round in 2024
Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.
GC Therapeutics
Series A in 2024
GC Therapeutics is a biotechnology company focused on the programming of patient-derived stem cells into various cell types using synthetic biology. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, allowing for efficient and scalable cell programming. Their technology enables the creation of customized cells, known as SuperCells™, tailored for specific medical conditions. With a foundation rooted in research from Professor George Church's lab at Harvard Medical School, GC Therapeutics aims to streamline the manufacturing process of unique cell therapies while enhancing cell quality and efficiency. The company is composed of a team of biologists and tissue engineers committed to advancing this innovative approach to improve patient outcomes.
Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.
Levels is a health and wellness company founded in 2019 that focuses on monitoring metabolic fitness through a wearable device. The platform tracks blood glucose levels in real-time, providing users with immediate feedback about their unique metabolic responses to diet and lifestyle choices. This data enables clients to optimize their nutrition and exercise routines according to their personal health goals. Operating as a remote-first company, Levels aims to empower individuals to take control of their metabolic health through advanced technology and tailored insights.
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
Q Bio
Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Formation Bio
Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Talkiatry
Series C in 2024
Talkiatry is a provider of virtual, in-network psychiatry services, connecting patients with a team of over 300 licensed psychiatrists. The company focuses on delivering evaluation, diagnosis, and personalized treatment plans, including medication management, for various mental health conditions such as anxiety, depression, ADHD, and substance use disorders. By employing an interactive process with evidence-based scales, Talkiatry facilitates on-the-spot preliminary diagnoses and assessments, thereby enhancing access to quality mental health care. The company's mission is to make high-quality psychiatric services both accessible and convenient for patients seeking treatment.
Santa Ana Bio
Series B in 2024
Santa Ana Bio is a biotechnology company focused on developing precision biologics for autoimmune and inflammatory diseases. The company employs advanced technologies, including deep cell profiling, multi-omics platforms, and single-cell genomics, to create targeted therapies. By utilizing antibody engineering and sophisticated analytics, Santa Ana Bio aims to deliver personalized treatments that enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.
Valar Labs
Series A in 2024
Valar Labs, founded in 2021 by Anirudh Joshi, Viswesh Krishna, Pranav Rajpurkar, and Damir Vrabac, is a healthcare technology company focused on enhancing cancer treatment through the use of artificial intelligence. The company has developed a software platform that analyzes imaging data, which is routinely collected in clinical settings, to provide oncologists with interpretable and actionable insights. By leveraging patient-specific characteristics, Valar Labs aims to support oncologists in making informed treatment decisions, ultimately improving patient outcomes in cancer care.
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Tennr is a healthcare AI startup focused on optimizing healthcare operations by automating back-office tasks. The company's platform leverages AI technology to replace traditional faxing systems and streamline communication processes in healthcare, ensuring patients receive timely care. By automating workflows, verifying information, analyzing data entry, and handling decision-making nuances, Tennr enables healthcare practices of all sizes to enhance their operational efficiency with high-quality automation.
Hippocratic AI
Series A in 2024
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.
Milu Health
Seed Round in 2024
Milu Health is a healthcare platform focused on simplifying and reducing the costs associated with medical care for employees. By leveraging electronic health records, claims, and pricing data, the company identifies cost-saving opportunities in healthcare. Milu Health provides price transparency data that helps users find high-quality, reasonably-priced doctors and hospitals for common procedures and surgeries. This enables patients to make informed decisions regarding their healthcare, ultimately leading to savings on doctor visits, procedures, prescription drugs, and medical bills.
Ambience Healthcare
Series B in 2024
Ambience Healthcare is a developer of an advanced artificial intelligence-powered medical scribe that aims to enhance clinician efficiency and alleviate burnout. Its Ambience AI operating system features a suite of synergistic applications designed to capture the nuances of clinician-patient conversations in real-time, generating comprehensive notes that integrate seamlessly into electronic medical record workflows. The system employs state-of-the-art speech recognition and custom-built AI to produce documentation in seconds while accommodating individual clinician preferences to reflect their unique style and voice. By utilizing Ambience's technology, healthcare systems can significantly reduce documentation time by an average of 78%, improve coding integrity, and achieve substantial returns on investment, ultimately enabling clinicians to close all their charts by the end of their shifts and achieve a better work-life balance.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Talofa is building games that make players mentally and physically healthier. Their flagship game on the platform, Run Legends, got over 300,000 downloads in the first 3 months and was featured as one of the "Best New Games" by Apple and Google Play Stores. Talofa’s team has been built up with game veterans from EA, 2K, and Riot Games and the CEO, Jenny Xu, has created mobile games with over 10M downloads.
Fortuna Health
Seed Round in 2023
Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage and receive timely notifications for recertification and renewal. This streamlined approach helps reduce care gaps and ensures clients are enrolled in the most suitable medical plan programs.
Waymark
Venture Round in 2023
Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.
Mana.bio
Seed Round in 2023
Mana.bio is an AI-based drug delivery company specializing in gene therapy, particularly in the development of DNA and RNA-based therapeutics and vaccines. The firm utilizes machine learning and nanotechnology to enhance the formulation of lipid nanoparticle systems, which are essential for oligonucleotide therapies. By integrating advanced technologies, Mana.bio aims to improve drug delivery services within the healthcare industry, facilitating more effective treatment options.
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
BetterLeap
Seed Round in 2023
BetterLeap is a specialized platform designed to assist healthcare professionals in advancing their careers by simplifying the job search process. It leverages artificial intelligence to automate and enhance the recruitment experience, allowing users to find job opportunities that align with their skills, aspirations, and values. The platform offers curated job listings and personalized recommendations, ensuring that users have access to relevant positions that suit their qualifications. With a user-friendly mobile application, BetterLeap aims to empower healthcare workers, from seasoned practitioners to newcomers, to make informed career moves efficiently and effectively. By streamlining the job search process, BetterLeap helps individuals in the healthcare sector navigate their career paths with greater ease and confidence.
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
Inceptive
Series A in 2023
Inceptive is a biotechnology company that specializes in designing RNA molecules through the integration of large-scale deep learning and high-throughput experimental methods. The company focuses on creating innovative biological software tools that facilitate the rational design of novel medicines and biotechnologies. By enabling the development of synthetic molecules for complex biological functions, Inceptive aims to advance healthcare and biotechnological solutions that were previously beyond reach, thus positioning itself at the forefront of medical and scientific innovation.
Caresync.website
Series A in 2023
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Hippocratic AI
Seed Round in 2023
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.
Memora Health
Venture Round in 2023
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.
Thatch
Pre Seed Round in 2023
Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.
Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.
Levels is a health and wellness company founded in 2019 that focuses on monitoring metabolic fitness through a wearable device. The platform tracks blood glucose levels in real-time, providing users with immediate feedback about their unique metabolic responses to diet and lifestyle choices. This data enables clients to optimize their nutrition and exercise routines according to their personal health goals. Operating as a remote-first company, Levels aims to empower individuals to take control of their metabolic health through advanced technology and tailored insights.
Pearl Health
Venture Round in 2022
Pearl Health is a healthcare technology company founded in 2020 that focuses on empowering primary care providers and organizations to enhance patient care and optimize financial performance within value-based care models. The company offers a care-delivery and billing platform that simplifies administrative burdens for physicians, allowing them to concentrate on patient care. Pearl Health provides a fixed per-member-per-month payment structure for traditional members, along with clinical insights through analytics and performance optimization services. By partnering with thousands of primary care providers across 44 states, Pearl aims to improve healthcare quality, lower overall costs, and reward providers for keeping patients healthy. The company's team comprises physicians, public health experts, technologists, and risk management professionals who are committed to addressing significant challenges in the healthcare system.
Firefly Health
Venture Round in 2022
Firefly Health, Inc. is a healthcare company based in Wellesley, Massachusetts, founded in 2016. It specializes in providing primary health care services through an artificial intelligence-based platform that connects patients with healthcare professionals. The company focuses on a virtual-first primary care approach, allowing users to access live video appointments with primary care physicians and care teams. This model emphasizes convenience and accessibility without membership fees, enabling patients to make informed decisions about their health. Firefly Health aims to redefine patient care by blending advanced technology with a dedicated care team to ensure continuous and proactive support for common health conditions, including back pain, stomach flu, and women's health issues.
Rezo Therapeutics
Series A in 2022
Rezo Therapeutics is a biotechnology company that focuses on pioneering the integrated mapping of disease networks to develop precision therapeutics. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo combines proteomics, genetics, structural biology, chemistry, and bioinformatics to create comprehensive maps of molecular disease networks. This innovative approach enables oncologists and researchers to identify novel targets and therapies with greater clarity and precision than traditional drug discovery methods. Initially concentrating on oncology, Rezo Therapeutics plans to expand its therapeutic focus through collaborations and partnerships, aiming to address a wide range of diseases.
Revero is an online clinic established in 2019 and based in San Francisco, California, that focuses on treating chronic conditions through a root-cause approach. The company offers personalized treatments for autoimmune and metabolic conditions, primarily utilizing nutrition therapy and remote medical care. Revero's platform integrates clinical expertise with machine learning and digital tools, allowing patients to track their historical progress and receive feedback on their health journey. The primary objective of Revero is to assist patients in lowering blood sugar, enhancing metabolic health, reducing inflammation, and restoring gut health.
Cipher Skin
Venture Round in 2022
Cipher Skin Inc. is a technology company based in Denver, Colorado, founded in 2014. The company specializes in wearable technology that utilizes innovative mesh sensors to conform to the human body, enabling precise measurement and monitoring of vital data. Cipher Skin's platform captures three-dimensional motion data and biosignals, such as heart rate and oxygen saturation, without the need for cameras or bulky equipment. This technology provides actionable insights that can be trusted, allowing physical therapists and trainers to develop safe and effective programs by accurately assessing complex movements, particularly in the upper limbs. Through its advancements, Cipher Skin aims to create the largest and most accurate data DNA platform of the physical world.
Incredible Health
Series B in 2022
Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.
Vicinitas Therapeutics
Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
Cartography Biosciences
Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company aims to revolutionize cancer immunotherapies by identifying the safest and most effective targets for treatment. Utilizing a platform-based cell therapy approach, Cartography employs single-cell analysis to discover novel CAR-T targets. This methodology empowers clients to enhance their molecular biology and computational methods, facilitating the advancement of innovative cancer immunotherapies. By prioritizing precision and safety, Cartography Biosciences is dedicated to transforming the landscape of cancer treatment.
Tomorrow Health
Series B in 2022
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.
We create organic high-protein meals with high standards, backed by leading longevity research. Our standards: - 40-60g protein per meal - Nutrient-dense meat (grass-fed, pasture-raised, wild-caught) - No seed oils (cooked in extra virgin olive oil) - 8g+ fiber per meal - Organic, pesticide-free produce - No processed ingredients. No refined sugars - Microplastic-free, reusable glass jars - High in Anti-inflammatories, and Omega-3s Since starting in 2020, we’ve delivered 100K+ orders and are backed by a16z, Y-Combinator, Goodwater, Decent Capital, and other top investors.
Turquoise Health
Series A in 2022
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Octant Bio
Series B in 2022
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.
Memora Health
Venture Round in 2022
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.
Topography Health
Series A in 2022
Topography Health is a company that facilitates the participation of private practice physicians in clinical trials, thereby advancing medical research. It provides a comprehensive platform that assists medical practices in understanding their patient populations and identifying studies that are likely to be accepted and impactful. The company also aids in recruiting patients and managing research staff, effectively addressing the barriers that physicians often face when entering the research field. By enabling local clinical trials, Topography Health offers patients with diverse health conditions access to personalized medical research opportunities for the first time.
Nitra is a financial technology company focused on transforming the healthcare industry through innovative and efficient solutions. It provides a suite of machine learning-powered financial software that includes credit cards, loans, accounts, payments, and expense management tools specifically designed for medical professionals. Nitra's platform enables healthcare providers to streamline their financial operations, allowing them to balance patient care with practice management. Its offerings include a business card that rewards spending and fosters partnerships with various service providers, as well as user-friendly accounting and receipt reconciliation tools. Nitra is committed to equipping the healthcare sector with advanced technology and dedicated support, ensuring that financial management can be both effective and straightforward.
Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.
Ribbon Health
Series B in 2021
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the costs and quality of care. The platform offers services such as provider directories, referral management, care navigation, and insurance enrollment, catering to a diverse range of clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. Founded in 2016 and based in New York, the company was previously known as HealthWiz, Inc. before rebranding in March 2018. Ribbon Health provides the critical infrastructure necessary for accurate provider directories and efficient healthcare navigation, thereby enhancing the overall healthcare experience for its users.
Patina Health
Series A in 2021
Patina Health operates a specialized primary care model focused on improving healthcare outcomes for older adults. Their approach prioritizes personalization, accessibility, and family involvement, aiming to enhance the aging experience by addressing the unique needs of this demographic.
Sprinter Health
Series A in 2021
Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.
Pearl Health
Series A in 2021
Pearl Health is a healthcare technology company founded in 2020 that focuses on empowering primary care providers and organizations to enhance patient care and optimize financial performance within value-based care models. The company offers a care-delivery and billing platform that simplifies administrative burdens for physicians, allowing them to concentrate on patient care. Pearl Health provides a fixed per-member-per-month payment structure for traditional members, along with clinical insights through analytics and performance optimization services. By partnering with thousands of primary care providers across 44 states, Pearl aims to improve healthcare quality, lower overall costs, and reward providers for keeping patients healthy. The company's team comprises physicians, public health experts, technologists, and risk management professionals who are committed to addressing significant challenges in the healthcare system.
ROME Therapeutics
Series B in 2021
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.
Turquoise Health
Seed Round in 2021
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Bayesian Health
Venture Round in 2021
Bayesian Health Inc. is a digital health company headquartered in New York, New York, that specializes in developing an AI-driven platform designed to enhance patient care within hospital settings. The platform integrates with electronic medical records (EMR) systems to provide real-time data and actionable insights, allowing clinical staff and hospital leadership to monitor illness severity and detect changes in patient acuity. By leveraging artificial intelligence and machine learning, Bayesian Health's technology supports healthcare providers in making informed, data-driven decisions, thereby improving the efficiency and safety of patient care. Established in 2016, the company aims to optimize decision-making processes in complex clinical environments, ultimately increasing the capacity of frontline healthcare teams.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.
Memora Health
Venture Round in 2021
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
Tomorrow Health
Series A in 2021
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.
Firefly Health
Series B in 2021
Firefly Health, Inc. is a healthcare company based in Wellesley, Massachusetts, founded in 2016. It specializes in providing primary health care services through an artificial intelligence-based platform that connects patients with healthcare professionals. The company focuses on a virtual-first primary care approach, allowing users to access live video appointments with primary care physicians and care teams. This model emphasizes convenience and accessibility without membership fees, enabling patients to make informed decisions about their health. Firefly Health aims to redefine patient care by blending advanced technology with a dedicated care team to ensure continuous and proactive support for common health conditions, including back pain, stomach flu, and women's health issues.
AKASA is a leading developer of AI-powered automation solutions specifically designed for the healthcare revenue cycle. The company focuses on streamlining complex workflows, enabling healthcare providers to enhance revenue outcomes and operational efficiency. By applying advanced technologies such as artificial intelligence, AKASA automates time-consuming revenue cycle tasks, including prior authorization and claims processing, which were previously challenging to resolve at scale. This innovative approach helps healthcare institutions reduce accounts receivable days, increase efficiency, and save significant staff time, ultimately improving financial performance. AKASA's solutions are grounded in deep revenue cycle expertise and uphold high standards of data security, delivering reliable results with accuracy and speed. The company has raised over $200 million from notable investors to further its mission of simplifying the financial complexities in healthcare.
Komodo Health
Series E in 2021
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Levels is a health and wellness company founded in 2019 that focuses on monitoring metabolic fitness through a wearable device. The platform tracks blood glucose levels in real-time, providing users with immediate feedback about their unique metabolic responses to diet and lifestyle choices. This data enables clients to optimize their nutrition and exercise routines according to their personal health goals. Operating as a remote-first company, Levels aims to empower individuals to take control of their metabolic health through advanced technology and tailored insights.
FidoCure is dedicated to advancing cancer care for dogs through AI-driven precision medicine. The company utilizes data from naturally occurring canine cancers, combining next-generation sequencing with clinical insights to create the largest proprietary learning database for canine oncology. FidoCure offers personalized medicine services that go beyond traditional chemotherapy and radiation, collecting tissue samples for DNA sequencing to identify genetic mutations impacting treatment. This approach allows for the development of targeted therapies aimed at effectively attacking cancer cells. By bridging the gap between human and veterinary oncology, FidoCure enhances comparative oncology, improving treatment outcomes for both pets and humans while addressing a significant unmet need in canine cancer care.
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.
AKASA is a leading developer of AI-powered automation solutions specifically designed for the healthcare revenue cycle. The company focuses on streamlining complex workflows, enabling healthcare providers to enhance revenue outcomes and operational efficiency. By applying advanced technologies such as artificial intelligence, AKASA automates time-consuming revenue cycle tasks, including prior authorization and claims processing, which were previously challenging to resolve at scale. This innovative approach helps healthcare institutions reduce accounts receivable days, increase efficiency, and save significant staff time, ultimately improving financial performance. AKASA's solutions are grounded in deep revenue cycle expertise and uphold high standards of data security, delivering reliable results with accuracy and speed. The company has raised over $200 million from notable investors to further its mission of simplifying the financial complexities in healthcare.
PatientPing
Series C in 2020
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.
Octant Bio
Series A in 2020
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.
Topography Health
Venture Round in 2020
Topography Health is a company that facilitates the participation of private practice physicians in clinical trials, thereby advancing medical research. It provides a comprehensive platform that assists medical practices in understanding their patient populations and identifying studies that are likely to be accepted and impactful. The company also aids in recruiting patients and managing research staff, effectively addressing the barriers that physicians often face when entering the research field. By enabling local clinical trials, Topography Health offers patients with diverse health conditions access to personalized medical research opportunities for the first time.
Tomorrow Health
Seed Round in 2020
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.
Ribbon Health
Series A in 2020
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the costs and quality of care. The platform offers services such as provider directories, referral management, care navigation, and insurance enrollment, catering to a diverse range of clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. Founded in 2016 and based in New York, the company was previously known as HealthWiz, Inc. before rebranding in March 2018. Ribbon Health provides the critical infrastructure necessary for accurate provider directories and efficient healthcare navigation, thereby enhancing the overall healthcare experience for its users.
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Buck Stash
Series A in 2020
Buck Stash is a venture capital firm that specializes in seed, early, mid, and late stage investments. It prefers to invest in the social media business and technology sector, with a focus on software, back-end infrastructure, Internet infrastructure, cloud computing, enterprise software and services, consumer, business Internet, mobile Internet, consumer Internet, cloud computing, data-storage, social network browsers data-storage, consumer electronics, networking functions, software related biology, biotech, and medicine companies at the intersection of computer science and medicine
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Komodo Health
Series C in 2020
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.
Incredible Health
Series A in 2019
Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Health IQ
Series D in 2019
Health IQ is a health insurance marketplace focused on increasing health literacy and rewarding health-conscious individuals with lower insurance rates. The company aims to celebrate those dedicated to their health by providing them with affordable life and Medicare insurance options. Its platform utilizes users' current health status, health knowledge, and active lifestyles to better assess long-term health risks, allowing for more accurate insurance product recommendations. By promoting health literacy, Health IQ seeks to empower individuals to take control of their health and well-being while offering incentives for maintaining a healthy lifestyle.
FidoCure
Seed Round in 2019
FidoCure is dedicated to advancing cancer care for dogs through AI-driven precision medicine. The company utilizes data from naturally occurring canine cancers, combining next-generation sequencing with clinical insights to create the largest proprietary learning database for canine oncology. FidoCure offers personalized medicine services that go beyond traditional chemotherapy and radiation, collecting tissue samples for DNA sequencing to identify genetic mutations impacting treatment. This approach allows for the development of targeted therapies aimed at effectively attacking cancer cells. By bridging the gap between human and veterinary oncology, FidoCure enhances comparative oncology, improving treatment outcomes for both pets and humans while addressing a significant unmet need in canine cancer care.
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
AKASA is a leading developer of AI-powered automation solutions specifically designed for the healthcare revenue cycle. The company focuses on streamlining complex workflows, enabling healthcare providers to enhance revenue outcomes and operational efficiency. By applying advanced technologies such as artificial intelligence, AKASA automates time-consuming revenue cycle tasks, including prior authorization and claims processing, which were previously challenging to resolve at scale. This innovative approach helps healthcare institutions reduce accounts receivable days, increase efficiency, and save significant staff time, ultimately improving financial performance. AKASA's solutions are grounded in deep revenue cycle expertise and uphold high standards of data security, delivering reliable results with accuracy and speed. The company has raised over $200 million from notable investors to further its mission of simplifying the financial complexities in healthcare.
Ciitizen
Venture Round in 2018
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Health IQ
Series C in 2017
Health IQ is a health insurance marketplace focused on increasing health literacy and rewarding health-conscious individuals with lower insurance rates. The company aims to celebrate those dedicated to their health by providing them with affordable life and Medicare insurance options. Its platform utilizes users' current health status, health knowledge, and active lifestyles to better assess long-term health risks, allowing for more accurate insurance product recommendations. By promoting health literacy, Health IQ seeks to empower individuals to take control of their health and well-being while offering incentives for maintaining a healthy lifestyle.
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.
Shield Bio
Seed Round in 2017
Shield Bio is a biotechnology company focused on combating antibiotic resistance, a growing public health crisis projected to surpass cancer-related deaths by 2050. The company has developed a novel genomic testing platform that enables sexually transmitted infection (STI) clinics to accurately identify antibiotic-resistant strains of pathogens, particularly gonorrhea, which has shown resistance to multiple antibiotics. With approximately 820,000 new gonorrhea infections annually in the United States and the Centers for Disease Control and Prevention designating resistant strains as an urgent threat, Shield Bio's rapid and precise molecular antibiotic susceptibility testing is critical. This platform allows healthcare providers to determine the most effective antibiotics for treatment, thereby enhancing patient outcomes and helping to curb the spread of antibiotic resistance.
Medisas, Inc., based in the United States, is a company dedicated to improving hospital operations through innovative software solutions. Their cloud-based service facilitates seamless information transfer between doctors during shift changes, ensuring continuity of care. The company's team consists of experienced clinicians, engineers, and designers who are committed to reinventing hospital software. Medisas' record-keeping software focuses on key aspects such as shift change, patient transfer, and discharge, allowing healthcare organizations to maintain organization and enhance the quality of care provided.
PatientPing
Series B in 2016
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.